Jump to top menu Jump to main menu Jump to content
erlenmyer-research
Research group/lab  |  Image Analysis Core Laboratory

LungAnalysis

LungAnalysis, a pioneering image analysis core laboratory at Erasmus MC, specializes in the image analysis of pulmonary diseases, aiming to facilitate clinical research, diagnosis, and prognosis.

About our research group/lab

Our research

Background

Established in 2012, LungAnalysis is a structured collaboration between the Departments of Pediatric/Adult Pulmonology, Radiology and Nuclear Medicine, and Bioimaging Group Rotterdam (BIGR). LungAnalysis was founded by Prof. Dr. Harm Tiddens, who has been engaged in pulmonary structural and functional research since 1991. Since 2023, Dr. Daan Caudri has served as director of LungAnalysis, with Asst. Prof. Dr. Pierluigi Ciet as vice director.

Image Analyses

Chest CT outcome measures are becoming increasingly important in both clinical research and trials for cystic fibrosis (CF). Bronchiectasis, mucus plugging, and trapped air are well-validated outcome measures in CF, but traditional scoring systems are time-consuming and semi-quantitative. LungAnalysis co-developed and validated a sensitive alternative image analysis method, PRAGMA-CF, for scoring chest CT scans in both children and adults, through an ongoing collaboration with the Telethon Kids Institute in Perth, Australia. PRAGMA-CF has now been successfully used as a primary outcome measure in two large studies (RCTs in young children) and has proven significantly more sensitive in detecting early CF lung changes compared to previously used semi-quantitative scoring methods.

Over the years, LungAnalysis has adapted PRAGMA-CF scoring to a wide range of pulmonary diseases, and currently serves as an essential component of LungAnalysis’s image analysis portfolio: PRAGMA-BPD for bronchopulmonary dysplasia scoring, BEST-CT for bronchiectasis scoring, MERAGMA-PCD for primary ciliary dyskinesia scoring, PRAGMA-NTM for non-tuberculous mycobacteria infection scoring, and PRAGMA-PiBO for post-infectious bronchiolitis obliterans scoring. Additionally, LungAnalysis has extended these scoring methods to chest MRI with adaptations such as PRIME based on PRAGMA-CF and MERGE based on PRAGMA-BPD.

LungAnalysis has been working towards developing automated tools to quantify lung structural abnormalities. The lab has ongoing collaborations with Thirona B.V. (Nijmegen), a Dutch company specializing in cutting-edge artificial intelligence strategies for quantitative lung imaging. Together, LungAnalysis and Thirona co-developed a fully automated, sensitive system to measure bronchial widening, bronchial thickening, mucus plugging, and trapped air on chest CT. The algorithm has been integrated into Thirona’s certified software platform, LungQTM, which is installed on the virtual platform DRE at LungAnalysis, Erasmus MC. Current work on the validation of the automated tools is ongoing in a wide range of lung diseases, including CF.

Standardization of Chest CT Protocols

To make an optimal use of chest CT in research as well as clinical/patient care, standardization of image acquisition protocol is essential. LungAnalysis has successfully standardized over 200 participating centers worldwide, facilitated through an interactive website developed by LungAnalysis. LungAnalysis continues to provide training to centers globally.

Service Units

LungAnalysis operates through three core activities, each categorized into distinct service units.

  • Academic Research: Comprehensive range of academic research support, including standardizing protocols, image analysis, image analysis training, tool development, automation, validation, and clinical integration.
  • Non-academic Research: Efficient and cost-effective image analysis services for (non-)pharmaceutical industries.
  • Clinical/Patient Care: Accurate and reliable quantitative image analysis services for (inter-)national medical centers

Our projects

Key Publications

  • Pederiva F, Rothenberg SS, Hall N, Ijsselstijn H, Wong KKY, von der Thüsen J, Ciet P, Achiron R, Pio d'Adamo A, Schnater JM. Congenital lung malformations. Nature Review Disease Primers 2023 Nov 2;9(1):60.

Collaborations

Collaboration within Erasmus MC

  • Biomedical Imaging Group Rotterdam
  • Pulmonary Medicine
  • Generation R
  • Immunology

 

Collaboration Outside of Erasmus MC

  • Thirona B.V., AI Medical Image Analysis, Nijmegen, the Netherlands

Funding & Grants

  • Dr. Daan Caudri: American CF Foundation, setting up European network to collect CT data on structural lung diseases to be included in the European CF Society – Patient Registry (ECFS-PR), ENRICH project, 2023 - 2028.
  • Dr. Daan Caudri: Stichting Astma Bestrijding (SAB). Developing and validating an AI-supported chest CT score to diagnose Post-infectious Brochiolitis Obliterans (PiBO) in children, 2024 - 2026.
  • Assistant Prof. Dr. Pierluigi Ciet: Dutch Research Council (NWO), VENI grant, MRI in Interstitial Lung Disease (M-ILD), 2023 - 2026.
  • Assistant Prof. Dr. Pierluigi Ciet: European AIC Pathfinder, VLF-3D Spiro MRI, low field MR chest imaging, 2023 - 2026.

Career opportunities

Our team

Principal Investigator

  • Dr. Daan Caudri
    Director, LungAnalysis
  • Asst. Prof. Dr. Pierluigi Ciet
    Vice Director, LungAnalysis

LungAnalysis staff

  • Drs. Punit Makani, Head of LungAnalysis
  • M.Sc. Jorien van de Puttelaar, Project Manager
  • M.Sc. Merlijn Bonte, Lead Image Analyst

LungAnalysis PhD student

  • M.Sc. Ieva Aliukonyte
  • M.Sc. Pranali Raut
  • M.Sc. Cristina Cretu
  • M.Sc. Federico Mollica

Any questions?

Please contact our office if you have any questions or comments.

Contact form